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The current knowledge of the morphology of development and progression
of atherosclerotic lesions is owed to experimental studies conducted in ani-
mals fed high cholesterol diets (1-5). According to this model, the first step
is progressive infiltration by transcytosis of low density lipoproteins into the
subendothelial connective tissue. Subsequently, there is infiltration by the
monocytes, that adhere to the endothelium and migrate to the intima, where
they phagocyte the lipids, transforming them into foam cells. This is how the
fatty streak forms, considered to be the first morphologically recognizable
atherosclerotic lesion. Progressive accumulation of lipids is favored by the
bradytrophic metabolism of the arterial wall. In fact, the metabolic rate of the
arterial wall depends on the process of filtration of nutrient substances, as
capillaries are largely absent in the wall. Therefore, by altering the filtration
process, the deposition of lipids favors yet further deposition, creating a vi-
cious circle. In these conditions, the morphological picture is characterized by
the accumulation of passive lipid deposits that predominate over the cell
defense reactions.
The reaction of the smooth muscle cells (SMCs) of the tunica media is
considered to be secondary to the above process, contributing to the phago-
cytic and intimal thickening processes. Thus, the myocytic reaction is not
attributed a significant weight in the birth of the atherosclerotic process.
Results of our research on the harmful effects of cigarette smoke, in par-
ticular, on the arterial wall (6-11) have contributed to better delineate the
morpho-functional picture of onset and development of atherosclerosis. In the
fetal arteries, the reaction powers of the SMCs are especially marked (6). In
these conditions, our observations have demonstrated that surprisingly, in
fetuses of smoking mothers, the very first defense reaction is morphological
alteration of the architecture of the tunica media. In absence of morphologi-
cally apparent lesions of the endothelium and subendothelial connective tis-
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sue, the early morphologically observable alteration is the appearance of columns
of cells running down from the muscular tunica and perpendicularly infiltrat-
ing the intima, as if attempting to block penetration of the molecules of the
gaseous products circulating in the blood (Figure 1).
These histopathological alterations are associated with marked changes in
the biological homeostasis of the SMCs. Our molecular biology studies have,
in fact, revealed that the first biological reaction in these cells caused by the
gaseous products of nicotine combustion is intense activation of the c-fos
proto-oncogene. This gene belongs to the family of “Immediate Early Genes”,
so defined because of their characteristically rapid activation in response to
various injuries, due to the fact that they do not require protein synthesis. In
addition, the SMCs are transformed from the contractile or quiescent pheno-
type, characterized by the presence of α-actin, into the synthetic or activated
type, showing loss of the contractile function and a switch in actin expression
from the α- to the β-form, a protein usually expressed by fibroblasts (Figure
2). Gabbiani et al. (11,12) have defined these dedifferentiated cells as
“myofibroblasts”, having features in common with both SMCs and fibroblasts.
These activated SMCs, or myofibroblasts, start to produce collagen, elastin
and extracellular matrix material and reacquire the primordial characteristic of
ameboid movement, enabling them to leave the media, which appears sub-
verted and thinned, and to move through the intima towards the lumen.
If the passive smoke injury persists, the activation process of the myofibroblasts
successively promotes their proliferation, as demonstrated by the PCNA-positivity
observed in the arterial walls in infants a few months old (7,9,11). In fact,
PCNA, mainly expressed during the S-phase of the cell cycle, is a specific
marker of cellular replication. The biological evolution of the lesions is char-
acterized by the maintenance of a delicate balance between cell proliferation
and apoptosis of the SMCs and the beginning of cytogenetic alterations, in
particular trisomy of chromosome 7, so that the atherosclerotic process resem-
bles that of a benign tumor (14,15).
Figure 1. Early morphologically observable atherosclerotic alteration in a coronary artery.
Trichromic Heidenhain (Azan) stain, 400x.
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These observations have allowed us to interpret the atherosclerotic process
not, as previously believed, as the consequence of a passive accumulation of
lipid materials, first in the intima and then in the media of an arterial wall
lacking the ability to react.
The atherosclerosis is the expression of the reaction of myofibroblasts to
the action of harmful agents. During evolution of the condition, if there is
continual deposition of lipid substances, these will predominate and foster an
overwhelming monocytic infiltration. The inflammatory type reaction should
thus be regarded as a secondary event, classifiable as inflammation in re-
sponse to a foreign body but not determined by microorganisms. In fact,
research has never brought to light the presence of infectious microorganisms
such as the Coxsackie or herpes virus or Chlamydia pneumoniae.
Moreover, our observations of atherosclerotic lesions in victims of non-
smoking mothers have led us to believe that yet other risk factors may play
Figure 2. The smooth muscle cells in early atherosclerotic lesions are transformed from
contractile or quiescent phenotype α-actin (A), into the activated type β-actin (B), usually
expressed by fibroblasts with loss of the contractile function and a switch in actin expres-
sion. Immunostaining for α-actin (A) and β-actin (B), 400x.
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a role contributing to trigger arterial wall alterations. Since most of the sub-
jects of our studies lived in large industrialized cities, we can hypothesize that
air pollution could also exert an atherogenic effect.
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